Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Zoetis Inc.
  6. Summary
    ZTS   US98978V1035

ZOETIS INC.

(ZTS)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/14/2021 06/15/2021 06/16/2021 06/17/2021 06/18/2021 Date
184.58(c) 185.67(c) 184.11(c) 186.44(c) 185.39 Last
3 695 658 1 629 722 1 933 789 1 245 452 3 334 702 Volume
+1.31% +0.59% -0.84% +1.27% -0.56% Change
More quotes
Financials (USD)
Sales 2021 7 593 M - -
Net income 2021 1 935 M - -
Net Debt 2021 2 884 M - -
P/E ratio 2021 45,1x
Yield 2021 0,49%
Sales 2022 8 128 M - -
Net income 2022 2 188 M - -
Net Debt 2022 1 799 M - -
P/E ratio 2022 39,6x
Yield 2022 0,56%
Capitalization 88 516 M 88 516 M -
EV / Sales 2021 12,0x
EV / Sales 2022 11,1x
Nbr of Employees 11 300
Free-Float 94,4%
More Financials
Company
Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product... 
Sector
Pharmaceuticals
Calendar
07/19Earnings Release
More about the company
Ratings of Zoetis Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about ZOETIS INC.
06/14Fiserv Appoints Wafaa Mamilli to Board of Directors
AQ
06/10ZOETIS  : A.L.P.H.A. Initiative Improves Livestock Health and Farmers' Livelihoo..
BU
06/03ZOETIS  : Releases 2020 Sustainability Report and Creates the Zoetis Foundation,..
BU
06/01ZOETIS  : Adds Devices for Use in Regenerative Medicine Therapies to its Growing..
PU
05/28ZOETIS  : Argus Adjusts Zoetis' Price Target to $195 From $185, Maintains Buy Ra..
MT
05/27ZOETIS  : to Participate in the William Blair 41st Annual Growth Stock Conferenc..
BU
05/24ZOETIS  : Insider Makes Sale of Zoetis (ZTS) Shares Slowing 90 Day Buying Trend
MT
05/24ZOETIS  : to Participate in the Stifel 2021 Virtual Jaws & Paws Conference
BU
05/21INSIDER TRENDS : Insider Sales Add to 90-Day Trend at Zoetis
MT
05/21ZOETIS INC.  : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/20ZOETIS  : Keeps Quarterly Dividend Steady at $0.25 Per Share, Payable Sept. 1 to..
MT
05/20ZOETIS  : Announces Results of Its Annual Meeting of Shareholders; Board Declare..
PU
05/20ZOETIS INC.  : Regulation FD Disclosure, Financial Statements and Exhibits (form..
AQ
05/20ZOETIS  : Announces Results of Its Annual Meeting of Shareholders; Board Declare..
BU
05/12ZOETIS  : Driven to Care in Costa Rica
PU
More news
News in other languages on ZOETIS INC.
05/06STOCK MARKET PARIS : Tout augmente, mon pauvre monsieur
05/06EN DIRECT DES MARCHES  : Société Générale, ArcelorMittal, EssilorLuxottica, Air ..
02/16Londres et Paris dopées aux vaccins, aux cycliques et à Vivendi
02/16EN DIRECT DES MARCHES  : Michelin, TechnipFMC, Sanofi, Faurecia, Vicat, BHP, Gle..
2020EN DIRECT DES MARCHES  : ArcelorMittal, Société Générale, Veolia, CGG, Lufthansa..
More news
Analyst Recommendations on ZOETIS INC.
More recommendations
Chart ZOETIS INC.
Duration : Period :
Zoetis Inc. Technical Analysis Chart | ZTS | US98978V1035 | MarketScreener
Technical analysis trends ZOETIS INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 190,06 $
Last Close Price 186,44 $
Spread / Highest target 13,2%
Spread / Average Target 1,94%
Spread / Lowest Target -23,8%
EPS Revisions
Managers and Directors
NameTitle
Kristin C. Peck Chief Executive Officer & Director
Wetteny Joseph CFO, EVP & Head-Business Development
Michael B. McCallister Non-Executive Chairman
Catherine Ann Knupp Executive VP, President-Research & Development
Wafaa Mamilli Chief Information Officer & Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
ZOETIS INC.12.65%88 516
ELANCO ANIMAL HEALTH INCORPORATED16.47%16 895
DECHRA PHARMACEUTICALS PLC26.26%6 568
JINYU BIO-TECHNOLOGY CO., LTD.-16.42%3 048
VIRBAC18.07%2 824
WUHAN KEQIAN BIOLOGY CO.,LTD-6.68%2 817